Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
AJR Am J Roentgenol ; 208(5): 1082-1088, 2017 May.
Artigo em Inglês | MEDLINE | ID: mdl-28267354

RESUMO

OBJECTIVE: We calculated body size-specific organ and effective doses for 23,734 participants in the National Lung Screening Trial (NLST) using a CT dose calculator. MATERIALS AND METHODS: We collected participant-specific technical parameters of 23,734 participants who underwent CT in the clinical trial. For each participant, we calculated two sets of organ doses using two methods. First, we computed body size-specific organ and effective doses using the National Cancer Institute CT (NCICT) dosimetry program, which is based on dose coefficients derived from a library of body size-dependent adult male and female computational phantoms. We then recalculated organ and effective doses using dose coefficients from reference size phantoms for all examinations to investigate potential errors caused by the lack of body size consideration in the dose calculations. RESULTS: The underweight participants (body mass index [BMI; weight in kilograms divided by the square of height in meters] < 18.5) received 1.3-fold greater lung dose (median, 4.93 mGy) than the obese participants (BMI > 30) (3.90 mGy). Thyroid doses were approximately 1.3- to 1.6-fold greater than the lung doses (6.3-6.5 mGy). The reference phantom-based dose calculation underestimates the body size-specific lung dose by up to 50% for the underweight participants and overestimates that value by up to 200% for the overweight participants. The median effective dose ranges from 2.01 mSv in obese participants to 2.80 mSv in underweight participants. CONCLUSION: Body size-specific organ and effective doses were computed for 23,734 NLST participants who underwent low-dose CT screening. The use of reference size phantoms can lead to significant errors in organ dose estimates when body size is not considered in the dose assessment.


Assuntos
Tamanho Corporal , Neoplasias Pulmonares/diagnóstico por imagem , Programas de Rastreamento , Radiografia Torácica/métodos , Tomografia Computadorizada por Raios X/métodos , Idoso , Feminino , Humanos , Neoplasias Pulmonares/epidemiologia , Masculino , Pessoa de Meia-Idade , Tamanho do Órgão , Imagens de Fantasmas , Doses de Radiação , Fumar/epidemiologia , Estados Unidos/epidemiologia
2.
JAMA ; 307(22): 2400-9, 2012 Jun 13.
Artigo em Inglês | MEDLINE | ID: mdl-22692172

RESUMO

CONTEXT: Use of diagnostic imaging has increased significantly within fee-for-service models of care. Little is known about patterns of imaging among members of integrated health care systems. OBJECTIVE: To estimate trends in imaging utilization and associated radiation exposure among members of integrated health care systems. DESIGN, SETTING, AND PARTICIPANTS: Retrospective analysis of electronic records of members of 6 large integrated health systems from different regions of the United States. Review of medical records allowed direct estimation of radiation exposure from selected tests. Between 1 million and 2 million member-patients were included each year from 1996 to 2010. MAIN OUTCOME MEASURE: Advanced diagnostic imaging rates and cumulative annual radiation exposure from medical imaging. RESULTS: During the 15-year study period, enrollees underwent a total of 30.9 million imaging examinations (25.8 million person-years), reflecting 1.18 tests (95% CI, 1.17-1.19) per person per year, of which 35% were for advanced diagnostic imaging (computed tomography [CT], magnetic resonance imaging [MRI], nuclear medicine, and ultrasound). Use of advanced diagnostic imaging increased from 1996 to 2010; CT examinations increased from 52 per 1000 enrollees in 1996 to 149 per 1000 in 2010, 7.8% annual increase (95% CI, 5.8%-9.8%); MRI use increased from 17 to 65 per 1000 enrollees, 10% annual growth (95% CI, 3.3%-16.5%); and ultrasound rates increased from 134 to 230 per 1000 enrollees, 3.9% annual growth (95% CI, 3.0%-4.9%). Although nuclear medicine use decreased from 32 to 21 per 1000 enrollees, 3% annual decline (95% CI, 7.7% decline to 1.3% increase), PET imaging rates increased after 2004 from 0.24 to 3.6 per 1000 enrollees, 57% annual growth. Although imaging use increased within all health systems, the adoption of different modalities for anatomic area assessment varied. Increased use of CT between 1996 and 2010 resulted in increased radiation exposure for enrollees, with a doubling in the mean per capita effective dose (1.2 mSv vs 2.3 mSv) and the proportion of enrollees who received high (>20-50 mSv) exposure (1.2% vs 2.5%) and very high (>50 mSv) annual radiation exposure (0.6% vs 1.4%). By 2010, 6.8% of enrollees who underwent imaging received high annual radiation exposure (>20-50 mSv) and 3.9% received very high annual exposure (>50 mSv). CONCLUSION: Within integrated health care systems, there was a large increase in the rate of advanced diagnostic imaging and associated radiation exposure between 1996 and 2010.


Assuntos
Sistemas Pré-Pagos de Saúde/estatística & dados numéricos , Imageamento por Ressonância Magnética/estatística & dados numéricos , Doses de Radiação , Tomografia Computadorizada por Raios X/estatística & dados numéricos , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Criança , Pré-Escolar , Prestação Integrada de Cuidados de Saúde , Feminino , Humanos , Lactente , Imageamento por Ressonância Magnética/tendências , Masculino , Prontuários Médicos , Pessoa de Meia-Idade , Estudos Retrospectivos , Tomografia Computadorizada por Raios X/tendências , Estados Unidos , Adulto Jovem
3.
AJR Am J Roentgenol ; 197(5): 1165-9, 2011 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-22021510

RESUMO

OBJECTIVE: The objective of our study was to determine the distribution of effective dose associated with a single low-dose CT chest examination of average-size participants in the National Lung Screening Trial. Organ doses were also investigated. MATERIALS AND METHODS: Thirty-three sites nationwide provided volume CT dose index (CTDI(vol)) data annually for the 97 MDCT scanners used to image 26,724 participants during the trial. The dose data were representative of the imaging protocols used by the sites for average-size participants. Effective doses were estimated first using the product of the dose-length product (CTDI(vol) × 35-cm scan length) and a published conversion factor, "k." The commercial software product CT-Expo was then used to estimate organ doses to males and females from the average CTDI(vol). Applying tissue-weighting factors from both publication 60 and the more recent publication 103 of the International Commission on Radiological Protection (ICRP) allowed comparisons of effective doses to males and to females. RESULTS: The product of DLP and the k factor resulted in a mean effective dose of 1.4 mSv (SD = 0.5 mSv) for a low-dose chest examination across all scanners. The CT-Expo results based on ICRP 60 tissue-weighting factors yielded effective doses of 1.6 and 2.1 mSv for males and females, respectively, whereas CT-Expo results based on ICRP 103 tissue-weighting factors resulted in effective doses of 1.6 and 2.4 mSv, respectively. CONCLUSION: Acceptable chest CT screening can be accomplished at an overall average effective dose of approximately 2 mSv as compared with an average effective dose of 7 mSv for a typical standard-dose chest CT examination.


Assuntos
Neoplasias Pulmonares/diagnóstico por imagem , Doses de Radiação , Radiografia Torácica/métodos , Radiometria/métodos , Tomografia Computadorizada por Raios X/métodos , Idoso , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Imagens de Fantasmas , Estados Unidos
4.
AJR Am J Roentgenol ; 194(6): 1539-46, 2010 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-20489094

RESUMO

OBJECTIVE: The National Lung Screening Trial includes 33 participating institutions that performed 75,133 lung cancer screening CT examinations for 26,724 subjects during 2002-2007. For trial quality assurance reasons, CT radiation dose measurement data were collected from all MDCT scanners used in the trial. MATERIALS AND METHODS: A total of 247 measurements on 96 MDCT scanners were collected using a standard CT dose index (CTDI) measurement protocol. The scan parameters used in the measurements (tube voltage, milliampere-seconds [mAs], and detector-channel configuration) were set according to trial protocol for average size subjects. The normalized weighted CT dose index (CTDI(w)) (computed as CTDI(w)/mAs) obtained from each trial-participating scanner was tabulated. RESULTS: We found a statistically significant difference in normalized CT dose index among CT scanner manufacturers, likely as a result of design differences, such as filtration, bow-tie design, and geometry. Our findings also indicated a statistically significant difference in normalized CT dose index among CT scanner models from the same manufacturer (e.g., GE Healthcare, Siemens Healthcare, and Philips Healthcare). We also found a statistically significant difference in normalized CT dose index among all models and all manufacturers; furthermore, we found a statistically significant difference in normalized CT dose index among CT scanners from all manufacturers when we compared scanners with four or eight data channels to those with 16, 32, or 64 channels, suggesting that more complex scanners have improved dose efficiency. CONCLUSION: Average normalized CT dose index values varied by a factor of almost two for all scanners from all manufacturers. This study was focused on machine-specific normalized CT dose index; patient dose and image quality were not addressed.


Assuntos
Neoplasias Pulmonares/diagnóstico por imagem , Radiometria/métodos , Tomógrafos Computadorizados/normas , Tomografia Computadorizada por Raios X/normas , Ensaios Clínicos como Assunto , Humanos , Garantia da Qualidade dos Cuidados de Saúde , Doses de Radiação , Estados Unidos
5.
J Ind Microbiol Biotechnol ; 33(1): 29-36, 2006 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-16328508

RESUMO

Bacteria and fungi, isolated from United States Air Force (USAF) aviation fuel samples, were identified by gas chromatograph fatty acid methyl ester (GC-FAME) profiling and 16S or 18S rRNA gene sequencing. Thirty-six samples from 11 geographically separated USAF bases were collected. At each base, an above-ground storage tank, a refueling truck, and an aircraft wing tank were sampled at the lowest sample point, or sump, to investigate microbial diversity and dispersion within the fuel distribution chain. Twelve genera, including four Bacillus species and two Staphylococcus species, were isolated and identified. Bacillus licheniformis, the most prevalent organism isolated, was found at seven of the 11 bases. Of the organisms identified, Bacillus sp., Micrococcus luteus, Sphinogmonas sp., Staphylococcus sp., and the fungus Aureobasidium pullulans have previously been isolated from aviation fuel samples. The bacteria Pantoea ananatis, Arthrobacter sp., Alcaligenes sp., Kocuria rhizophilia, Leucobacter komagatae, Dietza sp., and the fungus Discophaerina fagi have not been previously reported in USAF aviation fuel. Only at two bases were the same organisms isolated from all three sample points in the fuel supply distribution chain. Isolation of previously undocumented organisms suggests either, changes in aviation fuel microbial community in response to changes in aviation fuel composition, additives and biocide use, or simply, improvements in isolation and identification techniques.


Assuntos
Aeronaves , Bactérias/isolamento & purificação , Óleos Combustíveis/microbiologia , Fungos/isolamento & purificação , RNA Ribossômico 16S/genética , Bactérias/classificação , Contaminação de Equipamentos , Fungos/classificação , Genes de RNAr/genética , Hidrocarbonetos , RNA Ribossômico 16S/análise , Estados Unidos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...